Evidence map›Paper›PMID 19487023›Full record

ArticleCell calcium2009

Calcium-independent phospholipase A2 participates in KCl-induced calcium sensitization of vascular smooth muscle.

Paul H Ratz, Amy S Miner, Suzanne E Barbour

Abstract read
In one paragraph

Article in Cell calcium, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Enhanced KCl-mediated contractility and CaAmerican journal of physiology. Heart and circulatory physiology · 2020
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Active tension adaptation at a shortened arterial muscle length: inhibition by cytochalasin-D.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul H RatzDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, USA. phratz@vcu.edu
Amy S Miner
Suzanne E Barbour
Virginia Commonwealth University · US

Funding

Regulation of vascular smooth muscle calcium sensitivityR01HL061320 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI RATZ, PAUL H · 2001 to 2010
$2.3M
NHLBI NIH HHS R01 HL061320NHLBI NIH HHS R01-HL61320
6 · The paper itself

Abstract

In vascular smooth muscle, KCl not only elevates intracellular free Ca(2+) ([Ca(2+)](i)), myosin light chain kinase activity and tension (T), but also can inhibit myosin light chain phosphatase activity by activation of rhoA kinase (ROCK), resulting in Ca(2+) sensitization (increased T/[Ca(2+)](i) ratio). Precisely how KCl causes ROCK-dependent Ca(2+) sensitization remains to be determined. Using Fura-2-loaded isometric rings of rabbit artery, we found that the Ca(2+)-independent phospholipase A(2) (iPLA(2)) inhibitor, bromoenol lactone (BEL), reduced the KCl-induced tonic but not early phasic phase of T and potentiated [Ca(2+)](i), reducing Ca(2+) sensitization. The PKC inhibitor, GF-109203X (> or =3 microM) and the pseudo-substrate inhibitor of PKCzeta produced a response similar to BEL. BEL reduced basal and KCl-stimulated myosin phosphatase phosphorylation. Whereas BEL and H-1152 produced strong inhibition of KCl-induced tonic T (approximately 50%), H-1152 did not induce additional inhibition of tissues already inhibited by BEL, suggesting that iPLA(2) links KCl stimulation with ROCK activation. The cPLA(2) inhibitor, pyrrolidine-1, inhibited KCl-induced tonic increases in [Ca(2+)](i) but not T, whereas the inhibitor of 20-HETE production, HET0016, acted like the ROCK inhibitor H-1152 by causing Ca(2+) desensitization. These data support a model in which iPLA(2) activity regulates Ca(2+) sensitivity.

Indexed as

5,8,11,14-Eicosatetraynoic AcidAnimalsArachidonic AcidCalciumKineticsMuscle ContractionMuscle, Smooth, VascularMuscle TonusMyosin-Light-Chain KinaseNaphthalenesPhenylephrinePhospholipases A2, Calcium-IndependentPotassium ChlorideProtein Kinase CProtein Kinase C zetaPyrones5,8,11,14-Eicosatetraynoic Acid6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-oneArachidonic AcidCalciumMyosin-Light-Chain KinaseNaphthalenesPhenylephrinePhospholipases A2, Calcium-IndependentPotassium ChlorideProtein Kinase CProtein Kinase C zetaPyronespyrrolidinePyrrolidinesrho-Associated Kinases

Identifiers

PMID19487023
PMCPMC2703694
OpenAlexW2053164529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.